dipyridamole has been researched along with nitroarginine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Abman, SH; Clarke, WR; Fox, JJ; Ivy, DD; Kinsella, JP; Ziegler, JW | 1 |
Abraham, RZ; Kobzik, L; Moody, MR; Reid, MB; Stamler, JS | 1 |
3 other study(ies) available for dipyridamole and nitroarginine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus.
Topics: Acetylcholine; Adenosine; Animals; Aorta; Blood Pressure; Dipyridamole; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Fetus; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Pulmonary Artery; Pulmonary Circulation; Sheep; Vascular Resistance; Vasodilation; Vasodilator Agents | 1998 |
Cyclic GMP is a second messenger by which nitric oxide inhibits diaphragm contraction.
Topics: Aminoquinolines; Animals; Cyclic GMP; Diaphragm; Dipyridamole; Enzyme Inhibitors; Guanylate Cyclase; Male; Muscle Contraction; Nitric Oxide; Nitroarginine; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Second Messenger Systems | 1998 |